Your session is about to expire
What is Bontril
Approved as Treatment by the FDA
Phendimetrazine, otherwise known as Bontril PDM, is approved by the FDA for 1 uses including Exogenous Obesity .Effectiveness
When to interrupt dosage
The prescribed measure of Bontril is contingent upon the diagnosed ailment. The amount likewise differs depending on the approach of delivery (e.g. Capsule or Capsule, extended release - Oral) featured in the referenced table.Warnings
Bontril has twelve contraindications, thus it should not be ingested if any of the conditions in the table below are present.Bontril ContraindicationsBontril Novel Uses: Which Conditions Have a Clinical Trial Featuring Bontril?
No active trials are currently assessing the potential of Bontril to address Exogenous Obesity.Bontril Reviews: What are patients saying about Bontril?
Patient Q&A Section about bontril
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Does Bontril work for weight loss?
"Phendimetrazine is a drug that is used to help people lose weight by reducing their appetite. It is often used in conjunction with a doctor-approved diet and exercise program."
Is Bontril still available?
"The Bontril Slow Release product has been discontinued and is no longer available in the United States. If the Food and Drug Administration has approved generic versions of this product, there may be generic equivalents available from other manufacturers."
What does Bontril do?
"This medication is designed to be used alongside a doctor-approved weight loss plan that includes reducing calorie intake and exercising regularly. It works by suppressing appetite."
What is the difference between Bontril and phentermine?
"Bontril PDM can help you lose weight, but it shouldn't be used for long periods of time and it isn't for everyone. Adipex-P is effective at lowering appetite and helping with weight loss. Available in generic form, which is more affordable. You only need to take it for a short period of time."